Bioteque Management
Management criteria checks 1/4
We currently do not have sufficient information about the CEO.
Key information
Jin-Long Lin
Chief executive officer
n/a
Total compensation
| CEO salary percentage | n/a |
| CEO tenure | 2.5yrs |
| CEO ownership | 0.3% |
| Management average tenure | no data |
| Board average tenure | 2.5yrs |
Recent management updates
Recent updates
A Look At The Fair Value Of Bioteque Corporation (GTSM:4107)
Apr 26
Should You Buy Bioteque Corporation (GTSM:4107) For Its Dividend?
Mar 29Bioteque Corporation's (GTSM:4107) Fundamentals Look Pretty Strong: Could The Market Be Wrong About The Stock?
Mar 11The Trends At Bioteque (GTSM:4107) That You Should Know About
Feb 24Update: Bioteque (GTSM:4107) Stock Gained 51% In The Last Three Years
Feb 09Estimating The Intrinsic Value Of Bioteque Corporation (GTSM:4107)
Jan 25Bioteque (GTSM:4107) Has A Rock Solid Balance Sheet
Jan 10
Does Bioteque Corporation (GTSM:4107) Have A Place In Your Dividend Portfolio?
Dec 25Are Bioteque Corporation's (GTSM:4107) Fundamentals Good Enough to Warrant Buying Given The Stock's Recent Weakness?
Dec 10Will Bioteque (GTSM:4107) Multiply In Value Going Forward?
Nov 22CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Sep 30 2024 | n/a | n/a | NT$499m |
| Jun 30 2024 | n/a | n/a | NT$501m |
| Mar 31 2024 | n/a | n/a | NT$480m |
| Dec 31 2023 | n/a | n/a | NT$453m |
| Sep 30 2023 | n/a | n/a | NT$461m |
| Jun 30 2023 | n/a | n/a | NT$449m |
| Mar 31 2023 | n/a | n/a | NT$470m |
| Dec 31 2022 | n/a | n/a | NT$494m |
| Sep 30 2022 | n/a | n/a | NT$511m |
| Jun 30 2022 | n/a | n/a | NT$466m |
| Mar 31 2022 | n/a | n/a | NT$433m |
| Dec 31 2021 | NT$5m | NT$2m | NT$431m |
| Sep 30 2021 | n/a | n/a | NT$451m |
| Jun 30 2021 | n/a | n/a | NT$483m |
| Mar 31 2021 | n/a | n/a | NT$501m |
| Dec 31 2020 | NT$5m | NT$2m | NT$489m |
| Sep 30 2020 | n/a | n/a | NT$441m |
| Jun 30 2020 | n/a | n/a | NT$433m |
| Mar 31 2020 | n/a | n/a | NT$457m |
| Dec 31 2019 | NT$5m | NT$2m | NT$464m |
Compensation vs Market: Insufficient data to establish whether Jin-Long's total compensation is reasonable compared to companies of similar size in the TW market.
Compensation vs Earnings: Jin-Long's compensation has been consistent with company performance over the past year.
CEO
Jin-Long Lin
2.5yrs
Tenure
NT$4,855,000
Compensation
Mr. Jin-Long Lin served as a Director of Bioteque Corporation since June 24, 2013 until June 15, 2022 and serves as its Senior Vice President since March 30, 2005. He is General Manager of Bioteque Corpora...
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| VP & Director | 17.5yrs | NT$5.38m | 1.07% NT$ 88.7m | |
| Chairman | 27.9yrs | NT$11.65m | 1.05% NT$ 86.7m | |
| VP & Vice Chairman of the Board | 5.5yrs | NT$5.29m | 0.26% NT$ 21.3m | |
| Independent Director | 6.5yrs | NT$341.00k | no data | |
| Supervisor & Representative Director | 5.5yrs | NT$4.32m | 0.33% NT$ 27.5m | |
| Representative Director | 2.5yrs | NT$652.00k | no data | |
| Independent Director | 2.5yrs | NT$221.00k | no data | |
| Representative Director | 2.5yrs | no data | no data | |
| Director | 2.5yrs | NT$1.08m | 0.16% NT$ 13.3m | |
| Director | 2.5yrs | NT$1.08m | 0.18% NT$ 15.1m | |
| Independent Director | 1.5yrs | no data | no data | |
| Representative Director | 1.9yrs | no data | no data |
2.5yrs
Average Tenure
60yo
Average Age
Experienced Board: 4107's board of directors are not considered experienced ( 2.5 years average tenure), which suggests a new board.
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/23 09:04 |
| End of Day Share Price | 2024/12/23 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Bioteque Corporation is covered by 5 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Zhennan Lee | Jih Sun Securities Investment Consulting Co., Ltd. |
| Ming Hong Chu | KGI Securities Co. Ltd. |
| Hsiu Chi Lin | Masterlink Securities Corp. |